title: Interleukin-2 receptor-directed therapies: antibody- or cytokine-based targeting molecules.
authors.affiliation: Department of Medicine, Beth Israel Hospital, Harvard Medical School, Boston, Massachusetts.
authors.forename: T B
authors.initials: TB
authors.lastname: Strom
authors.forename: V R
authors.initials: VR
authors.lastname: Kelley
authors.forename: J R
authors.initials: JR
authors.lastname: Murphy
authors.forename: J
authors.initials: J
authors.lastname: Nichols
authors.forename: T G
authors.initials: TG
authors.lastname: Woodworth
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001327:Autoimmune Diseases / Q000628:therapy; D016207:Cytokines / Q000627:therapeutic use*; D006801:Humans; D000922:Immunotoxins / Q000627:therapeutic use*; D007938:Leukemia / Q000628:therapy; D008223:Lymphoma / Q000628:therapy; D015375:Receptors, Interleukin-2 / Q000502:physiology*
chemical_list: D000911:Antibodies, Monoclonal; D016207:Cytokines; D000922:Immunotoxins; D015375:Receptors, Interleukin-2